The potential role of elagolix for treating uterine bleeding associated to uterine myomas-Reference-Cited by-同舟云学术

The potential role of elagolix for treating uterine bleeding associated to uterine myomas

Published:2020-05-13 Issue:12 Volume:21 Page:1419-1430
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Barra Fabio¹²^ORCID,Vitale Salvatore Giovanni³^ORCID,Seca Marta¹²,Scala Carolina⁴,Leone Roberti Maggiore Umberto⁵,Cianci Antonio³,Ferrero Simone¹²^ORCID

Affiliation:

1. Academic Unit of Obstetrics and Gynaecology, IRCCS Ospedale Policlinico San Martino , Genova, Italy

2. Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (Dinogmi), University of Genova , Italy

3. Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania , Catania, Italy

4. Unit of Obstetrics and Gynecology, Gaslini Institute , Genova, Italy

5. Department of Gynecologic Oncology, IRCCS National Cancer Institute , Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1755254

Reference94 articles.

1. Uterine fibroid management: from the present to the future

2. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women

3. Why Leiomyomas Are Called Fibroids: The Central Role of Extracellular Matrix in Symptomatic Women

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental and new investigational drugs for the treatment of uterine fibroids;Expert Opinion on Investigational Drugs;2024-04-17

2. Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper;Gynecologic and Obstetric Investigation;2024

3. Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids;Expert Opinion on Drug Metabolism & Toxicology;2022-08-03

4. Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis;BMC Women's Health;2022-01-15

5. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas;Expert Opinion on Investigational Drugs;2021-08-04